Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Breast Cancer

Free Subscription Articles published in Cancer Epidemiol Biomarkers Prev Retrieve available abstracts of 108 articles: HTML format

Single Articles

April 2026
1. YUK JS, Kim BS, Kim BY, Park JY, et al
   Association between Menopausal Hormone Therapy and Cancer: A Nationwide Retrospective Cohort Study in South Korea.
   Cancer Epidemiol Biomarkers Prev. 2026;35:569-577.
   PubMed     Abstract available
   
   
   March 2026
2. CABRERA-LOPEZ M, Angeles-Llerenas A, de la Vara-Salazar E, Sanchez GI, et al
   Association of levonorgestrel-containing emergency contraceptive pills with breast cancer in premenopausal Latin American women: the PRECAMA study.
   Cancer Epidemiol Biomarkers Prev. 2026.
   PubMed     Abstract available
   
   
   
3. POTT J, Mason AM, Salo V, Kettunen J, et al
   PCSK9 and breast cancer survival: a Mendelian Randomization study.
   Cancer Epidemiol Biomarkers Prev. 2026.
   PubMed     Abstract available
   
   
   
4. JOHN EM, Koo J, Gomez SL, Keegan THM, et al
   Immigration and social factors, tumor stage, and risk of contralateral breast cancer in Asian American and Hispanic women.
   Cancer Epidemiol Biomarkers Prev. 2026.
   PubMed     Abstract available
   
   
   February 2026
5. NGUYEN THT, Jeon S, Yoon J, Park B, et al
   The Role of Adiposity and Lipid Biomarkers in Postmenopausal Breast Cancer Risk: A Causal Mediation Analysis Based on a Nationwide Cohort Study.
   Cancer Epidemiol Biomarkers Prev. 2026 Feb 9. doi: 10.1158/1055-9965.EPI-25-1504
   PubMed     Abstract available
   
   
   
6. BISTA S, Harsanyi H, Khan M, Nambayan R, et al
   Breast cancer screening among cancer survivors: a systematic review and meta-analysis.
   Cancer Epidemiol Biomarkers Prev. 2026 Feb 6. doi: 10.1158/1055-9965.EPI-25-1465
   PubMed     Abstract available
   
   
   
7. VALDEZ D, Abe JV, Bohmann P, Bogumil D, et al
   Ethnic Mixture and Body Mass Index as Modifiers of Breast Cancer Risk Among Native Hawaiian Women: Insights from the Multiethnic Cohort.
   Cancer Epidemiol Biomarkers Prev. 2026 Feb 5. doi: 10.1158/1055-9965.EPI-25-1101
   PubMed     Abstract available
   
   
   
8. NYANTE SJ, Kajita Y, Tan X, Cohen EA, et al
   Association between Participant Characteristics and Breast Parenchymal Texture Variation among Postmenopausal Women.
   Cancer Epidemiol Biomarkers Prev. 2026;35:301-310.
   PubMed     Abstract available
   
   
   January 2026
9. VIDAL GA, Katz J, Sadetsky N, Dabrowski EC, et al
   Sociodemographic Disparities in First-Line Treatment and Outcome Patterns in Women With HR+/HER2- Metastatic Breast Cancer.
   Cancer Epidemiol Biomarkers Prev. 2026.
   PubMed     Abstract available
   
   
   
10. WANG SS, Wu J, Wu AH, Cheng I, et al
    Associations of Proximity to Superfund Sites and Air Pollution with Breast Cancer Subtypes: Clues from a Case-Case Study and Call for Longitudinal Studies.
    Cancer Epidemiol Biomarkers Prev. 2026;35:7-9.
    PubMed     Abstract available
    
    
    
11. MOONEY SJ, Rundle AG
    Can We Interpret Analyses of Etiologic Heterogeneity When Molecular Markers Are Used to Classify Tumors?
    Cancer Epidemiol Biomarkers Prev. 2026;35:138-143.
    PubMed     Abstract available
    
    
    December 2025
12. ZHANG Z, Ray RM, An R, Klonoff-Cohen HS, et al
    Mammographic Density as a Mediator for Breast Cancer Risk: Pooled Analysis of Four Population-Based Case-Control Studies on Women with Screening Mammograms Under 50.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
13. LUI ML, Lee Argov EJ, Kehm RD, Karr AG, et al
    Social Drivers of Guideline- Discordant Breast Cancer Screening by Age and Mortality Risk.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
14. LI X, Shan Y, Yu Y, Zhang D, et al
    Negative emotions and breast cancer risk for women with benign breast disease: a prospective multicenter cohort study in China.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
15. VAN ALSTEN SC, Love MI, Calhoun BC, Butler EN, et al
    Identifying locally recurrent versus second primary breast cancer: Genomic versus clinical criteria from Carolina Breast Cancer Study Phase III.
    Cancer Epidemiol Biomarkers Prev. 2025 Dec 1. doi: 10.1158/1055-9965.EPI-25-1298
    PubMed     Abstract available
    
    
    
16. CASTON NE, Spees LP, Waters AR, Wheeler SB, et al
    Associations between Insurance Status, Financial Hardship, and Rurality on Receipt of Guideline-Concordant Mammography.
    Cancer Epidemiol Biomarkers Prev. 2025;34:2150-2157.
    PubMed     Abstract available
    
    
    
17. MCVICKER L, Gunathilake KAMP, Cardwell CR, Kunzmann AT, et al
    Metabolic Syndrome and the Risk of Breast, Endometrial, and Ovarian Cancer among Postmenopausal Women in the UK Biobank.
    Cancer Epidemiol Biomarkers Prev. 2025;34:2125-2134.
    PubMed     Abstract available
    
    
    November 2025
18. SHARIFF-MARCO S, Von Behren J, Chirikova E, Inamdar PP, et al
    Assessing upstream structural and social drivers of health in breast cancer survivorship: the Pathways Study Neighborhood Resource.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
19. NASH SH, Loeffler BT, Verhage E, Sorensen J, et al
    Comorbidities among American Indian and Alaska Native People with Cancer: A Surveillance, Epidemiology, and End Results-Medicare Study.
    Cancer Epidemiol Biomarkers Prev. 2025;34:1914-1923.
    PubMed     Abstract available
    
    
    October 2025
20. OBENG-GYASI S, Handley D, Plascak JJ, Anampa JD, et al
    Neighborhood Contexts and Healthcare Utilization in Patients with Breast Cancer Receiving Chemotherapy.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
21. EL MOHEB M, Shen C, Rabinovich E, Kim S, et al
    Predicting Health-Related Quality of Life Trajectories in Elderly Breast Cancer Patients: From Pre-Diagnosis to Long-Term Follow-up.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
22. PINHEIRO LC, Reeder-Hayes KE
    The Honest Broker: Reimagining the Roles of Health Services Research, Community Partnership, and Policymaking to Address Structural Determinants of Cancer Outcomes.
    Cancer Epidemiol Biomarkers Prev. 2025;34:1683-1685.
    PubMed     Abstract available
    
    
    
23. AL HASAN SM, Toriola AT
    Prevalence and Determinants of Mammography Use among Women Aged 40 to 49 Years in the United States.
    Cancer Epidemiol Biomarkers Prev. 2025;34:1759-1770.
    PubMed     Abstract available
    
    
    
24. HOLOWATYJ AN, Liu L, Munro HM, Perkins-Smith JJ, et al
    Income, Race, and Survival among Low-Income Black and White Americans with Lung, Breast, Prostate, or Colorectal Cancer.
    Cancer Epidemiol Biomarkers Prev. 2025;34:1749-1758.
    PubMed     Abstract available
    
    
    
25. TIMBRES J, Kohut K, Mavaddat N, Easton DF, et al
    Breast Cancer Polygenic Risk Score Associated with Outcomes after In Situ Breast Disease.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    September 2025
26. WANG X, Yang X, Chen R, Liu W, et al
    Aspirin Use and Risk of Breast Cancer Recurrence in Chinese Patients.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
27. CHEN JH, Slack Tidwell RS, Kai M, Lucci A, et al
    Impact of Postpartum Diagnosis on Survival of Women with Inflammatory Breast Cancer.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
28. KIM EY, Shin S, Chang Y, Ryu S, et al
    Serum Ferritin and Iron-Related Biomarkers in Relation to Breast Cancer Risk by Menopausal Status: A Prospective Cohort Study.
    Cancer Epidemiol Biomarkers Prev. 2025 Sep 8. doi: 10.1158/1055-9965.EPI-25-0923
    PubMed     Abstract available
    
    
    
29. CHOI HL, Jung W, Youn J, Kim B, et al
    Risk of Parkinson's Disease Among Breast Cancer Survivors: A Nationwide Cohort Study in South Korea.
    Cancer Epidemiol Biomarkers Prev. 2025 Sep 4. doi: 10.1158/1055-9965.EPI-25-0712
    PubMed     Abstract available
    
    
    August 2025
30. ABDOLLAHPOUR I, Darouei B, Amani-Beni R, Yazdi M, et al
    Lifetime Sunlight Exposure and Risk of Breast Cancer: A Population-based incident Case-Control Study.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
31. DONZELLA SM, Rogers M, O'Brien KM, Von Holle A, et al
    Sedentary time and breast cancer risk in the Sister Study Cohort.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
32. TELONIS AG, Hernandez AE, Borowsky PA, Reguero Hernandez ED, et al
    Molecular Portraits of Social Adversity in Breast Cancer: Neighborhood Disadvantage is Associated with Epigenetic Deregulation of Key Oncogenic Pathways.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
33. BOROWSKY PA, Nahodyl L, Sable S, Sierra MA, et al
    Residential Proximity to NPL Superfund Sites and High Particulate Matter Exposure is Associated with Increased Likelihood of Triple Negative Breast Cancer.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
34. LOEHRER EA, van der Baan FH, Mooij TM, Andrieu N, et al
    Breast Density Changes after Risk-Reducing Salpingo-oophorectomy in Women with a Pathogenic Germline Variant in BRCA1 or BRCA2.
    Cancer Epidemiol Biomarkers Prev. 2025;34:1295-1305.
    PubMed     Abstract available
    
    
    
35. YAGHJYAN L, Tamimi RM, Baker GM, Heng YJ, et al
    Associations of Stem Cell Markers with Lobular Involution in Benign Breast Tissue.
    Cancer Epidemiol Biomarkers Prev. 2025;34:1314-1321.
    PubMed     Abstract available
    
    
    
36. CARROLL JE, Guard HE, March D, Arcaro KF, et al
    Urinary Levels of Endocrine-Disrupting Chemicals and Breast Density in Young Women.
    Cancer Epidemiol Biomarkers Prev. 2025;34:1306-1313.
    PubMed     Abstract available
    
    
    July 2025
37. ALVAREZ SOTO A, Gan W, Tannenbaum S
    Racial Disparities in Pathologic Complete Response and Survival after Neoadjuvant Chemotherapy for Breast Cancer.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
38. FOWLER ME, Reeves HD, Smith MJ, Saini G, et al
    Structural determinants of racial disparities in breast cancer survival in Alabama.
    Cancer Epidemiol Biomarkers Prev. 2025 Jul 9. doi: 10.1158/1055-9965.EPI-25-0195
    PubMed     Abstract available
    
    
    
39. NAIR NM, Mendicino L, Fiorica PN, Omilian AR, et al
    The African-specific variant in the Duffy Antigen Receptor for Chemokines (DARC) gene, CD8+ T-cell density and Aggressive Breast Cancer Subtypes in Black Women.
    Cancer Epidemiol Biomarkers Prev. 2025 Jul 8. doi: 10.1158/1055-9965.EPI-25-0454
    PubMed     Abstract available
    
    
    
40. LAMBERT PC, Andersson TML, Myklebust TA, Moller B, et al
    Monitoring Temporal Trends in Cancer Survival: Choosing Appropriate Standards When Accounting for Age and Other-Cause Mortality Variation Over Time.
    Cancer Epidemiol Biomarkers Prev. 2025;34:1141-1148.
    PubMed     Abstract available
    
    
    June 2025
41. TAUB CJ, Hernandez AE, Borowsky PA, Ream M, et al
    Distinct Sources of Social Adversity, Stress, and Coping Mechanisms Among Breast Cancer Patients to Identify Areas for Intervention.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
42. FRITSCH-HUMBLET B, Jiao Y, Eon-Marchais S, Dondon MG, et al
    Body mass index, IGF1-related polymorphisms and risk of familial breast cancer in women with no BRCA1 or BRCA2 pathogenic variant.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
43. READING JM, Solk P, Starikovsky J, Song J, et al
    Effects of a Physical Activity mHealth Intervention (Fit2Thrive) on WCRF/AICR Cancer Prevention Score among Breast Cancer Survivors: A Secondary Data Analysis.
    Cancer Epidemiol Biomarkers Prev. 2025 Jun 9. doi: 10.1158/1055-9965.EPI-25-0167
    PubMed     Abstract available
    
    
    
44. MCTIERNAN A
    Lifestyle and Breast Cancer Risk: How Does It All Add Up?
    Cancer Epidemiol Biomarkers Prev. 2025;34:833-835.
    PubMed     Abstract available
    
    
    
45. FENLON J, Van Bibber N, Mahlow J, Yamoah K, et al
    Human Immunodeficiency Virus-Associated Differences in the Tumor Immune Microenvironment of Lung, Breast, and Prostate Cancers.
    Cancer Epidemiol Biomarkers Prev. 2025;34:860-867.
    PubMed     Abstract available
    
    
    
46. KELLY RL, Liu Y, Harris AR, Peng C, et al
    The Breast Tumor Immune Microenvironment of DNA Double-Strand Break Repair Pathogenic Variant Carriers Is Enriched with Tumor-Associated Macrophages.
    Cancer Epidemiol Biomarkers Prev. 2025;34:868-874.
    PubMed     Abstract available
    
    
    May 2025
47. WILSON OW, Matthews CE, Wojcik KM, Tarasenko YN, et al
    The Effects of Post-Diagnosis Recreational Aerobic Exercise among Breast Cancer Survivors: A Systematic Review/Meta-Analyses.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
48. AOKI RL, Alexeeff SE, Caan BJ, Kushi LH, et al
    Nativity and Healthy Lifestyle Index in a Pooled Cohort of Female Breast Cancer Survivors from Northern California.
    Cancer Epidemiol Biomarkers Prev. 2025 May 7. doi: 10.1158/1055-9965.EPI-24-1871
    PubMed     Abstract available
    
    
    April 2025
49. DUNN MR, Niu H, Li D, Emerson MA, et al
    Applying a novel measure of community-level healthcare access to assess breast cancer care timeliness.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
50. BERGIN ART, Te Marvelde L, Milne RL, Lara Gonzalez LE, et al
    Aboriginal and Torres Strait Islander females and survival from breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
51. TANG L, Wang Z, Hsiao HH, Kwan ML, et al
    Associations of Cruciferous Vegetable Intake with Breast Cancer Survival in a Diverse Population in the Pathways Study.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
52. ROHAN TE, Zhang C, Wang Y, Couch FJ, et al
    p16, COX-2, and Ki67 protein expression in DCIS and risk of ipsilateral invasive breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
53. VERDIESEN RMG, Shokouhi M, Burgess S, Canisius S, et al
    Causal effects of breast cancer risk factors across hormone receptor breast cancer subtypes: A two-sample Mendelian randomization study.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
54. LIMA SM, Palermo TM, Lee FF, Insaf TZ, et al
    Historical redlining and all-cause survival after breast cancer diagnosis.
    Cancer Epidemiol Biomarkers Prev. 2025 Apr 3. doi: 10.1158/1055-9965.EPI-24-1862
    PubMed     Abstract available
    
    
    
55. QIN B, Vyas M, Moore SC, Su X, et al
    Reproducibility of Plasma Metabolome Over 1 Year in a Population-based Cohort of Black Breast Cancer Survivors.
    Cancer Epidemiol Biomarkers Prev. 2025 Apr 3. doi: 10.1158/1055-9965.EPI-24-1646
    PubMed     Abstract available
    
    
    
56. MCDONALD JA
    Unveiling the Stroma: Reproductive Factors and the Tumor Microenvironment in African Breast Cancer.
    Cancer Epidemiol Biomarkers Prev. 2025;34:459-461.
    PubMed     Abstract available
    
    
    March 2025
57. OGBENNA BT, He X, Wu AH, Le Marchand L, et al
    Healthy Lifestyle Index and Breast Cancer Risk among Postmenopausal Women: The Multiethnic Cohort Study.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
58. DAVIS S, Lian M, Colditz GA, Davis KL, et al
    Racialized Economic Segregation, Treatment and Outcomes in Women with Triple-Negative Breast Cancer.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
59. REN Y, Maselko J, Tan X, Olshan AF, et al
    PATTERNS OF CHANGE IN EMOTIONAL AND FUNCTIONAL WELL-BEING FOLLOWING BREAST CANCER DIAGNOSIS.
    Cancer Epidemiol Biomarkers Prev. 2025 Mar 4. doi: 10.1158/1055-9965.EPI-24-0849
    PubMed     Abstract available
    
    
    
60. ALBERS FEM, Dashti SG, Lynch BM
    Epidemiologic Studies of Biomarkers and Their Role in Carcinogenesis: The Need for a Formal Causal Inference Approach.
    Cancer Epidemiol Biomarkers Prev. 2025;34:373-374.
    PubMed     Abstract available
    
    
    February 2025
61. PLASCAK JJ, Xing CY, Mooney SJ, Rundle AG, et al
    Neighborhood disinvestment predicts shorter cancer survival time among Black women diagnosed with invasive breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
62. SCHROTH W, Murdter TE, Schwab M
    Unraveling the Impact of Drug Metabolism on Tamoxifen Response in Breast Cancer.
    Cancer Epidemiol Biomarkers Prev. 2025;34:221-223.
    PubMed     Abstract available
    
    
    January 2025
63. WALKER B, Pollard E, Howard SP, Jones VM, et al
    The Role of Race/Ethnicity on the Association between Neighborhood Deprivation and Breast Cancer Outcomes among Kentucky Breast Cancer Patients years 2010-2022.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
64. HERNANDEZ AE, Borowsky PA, Nahodyl L, Pinheiro PS, et al
    A Neighborhood-Level Hispanic Paradox: the Interaction between Hispanic Density, Neighborhood Disadvantage, and Survival in Breast Cancer Patients.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
65. ALBERS FE, Swain CT, Lou MW, Dashti SG, et al
    Insulin and insulin-like growth factor and risk of postmenopausal estrogen receptor-positive breast cancer: a case-cohort analysis.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
66. MAVADDAT N, Ficorella L, Carver T, Lee A, et al
    Correction: Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model.
    Cancer Epidemiol Biomarkers Prev. 2025;34:205.
    PubMed    
    
    
    
67. ANAMPA JD, Lin S, Obeng-Gyasi S, Xue X, et al
    Treatment and Survival Differences between Patients with Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma of the Breast.
    Cancer Epidemiol Biomarkers Prev. 2025;34:125-132.
    PubMed     Abstract available
    
    
    December 2024
68. HUANG X, Lott PC, Hu D, Zavala VA, et al
    Evaluation of multiple breast cancer polygenic risk score panels in women of Latin American heritage.
    Cancer Epidemiol Biomarkers Prev. 2024 Dec 3. doi: 10.1158/1055-9965.EPI-24-1247
    PubMed     Abstract available
    
    
    
69. POURALI G, Toriola AT
    The Untapped Opportunities of Addressing Lifecourse Growth in Mammographic Breast Density and Breast Cancer Prevention in Non-Hispanic Black Women.
    Cancer Epidemiol Biomarkers Prev. 2024;33:1541-1543.
    PubMed     Abstract available
    
    
    
70. NABI O, Liu Y, Struthers J, Lian M, et al
    The Role of Residential Segregation in Treatment and Outcomes of Ductal Carcinoma In Situ of the Breast.
    Cancer Epidemiol Biomarkers Prev. 2024;33:1633-1639.
    PubMed     Abstract available
    
    
    
71. BIGHAM Z, Holder EX, Rodday AM, Breeze JL, et al
    Lifecourse Growth and Development Determinants of Mammographic Density in Black Women.
    Cancer Epidemiol Biomarkers Prev. 2024;33:1640-1650.
    PubMed     Abstract available
    
    
    November 2024
72. DENG Z, Visvanathan K
    Patterns of subsequent cancer incidence over time in patients with breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
73. MACLEHOSE RF, Ahern TP, Collin LJ, Li A, et al
    CYP2D6 Phenotype and Breast Cancer Outcomes: A Bias Analysis and Meta-Analysis.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
74. KOKA H, Tian Y, Deng L, Yu K, et al
    Mammographic density in relation to breast cancer risk factors among Chinese women.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
75. LORONA NC, Othus M, Malone KE, Linden HM, et al
    Metabolic syndrome and risks of breast cancer outcomes for luminal, triple-negative, and HER2-overexpressing subtypes.
    Cancer Epidemiol Biomarkers Prev. 2024 Nov 1. doi: 10.1158/1055-9965.EPI-24-1167
    PubMed     Abstract available
    
    
    
76. CURRO II, Teasdale CA, Wyatt LC, Foster V, et al
    Cancer Screening, Knowledge, and Fatalism among Chinese, Korean, and South Asian Residents of New York City.
    Cancer Epidemiol Biomarkers Prev. 2024;33:1475-1483.
    PubMed     Abstract available
    
    
    October 2024
77. KEHM RD, Genkinger JM, Knight JA, Maclnnis RJ, et al
    Physical activity during adolescence and early adulthood and breast cancer risk before age 40 years.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
78. ASHAD-BISHOP KC, Star J, Giaquinto AN, Smith RA, et al
    Changes in Breast Cancer Screening Prevalence in the US During the COVID-19 Pandemic, 2018-2022.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
79. SARMIENTO DD, Tumas N, Pereyra SA, Scruzzi GF, et al
    Social determinants of breast cancer screening: a multilevel analysis of proximal and distal factors related to the practice of mammography.
    Cancer Epidemiol Biomarkers Prev. 2024 Oct 3. doi: 10.1158/1055-9965.EPI-24-1001
    PubMed     Abstract available
    
    
    
80. MARCUS POST L, Pathak DR, Hamilton AS, Hirko KA, et al
    Adiposity throughout Adulthood and Risk of Young Onset Breast Cancer Tumor Subtypes in the Young Women's Health History Study.
    Cancer Epidemiol Biomarkers Prev. 2024 Oct 2. doi: 10.1158/1055-9965.EPI-24-1067
    PubMed     Abstract available
    
    
    
81. WOOF VG, Howell A, Fox L, McWilliams L, et al
    Are women's breast cancer risk appraisals in line with updated clinical risk estimates communicated? Results from a UK Family History Risk and Prevention Clinic.
    Cancer Epidemiol Biomarkers Prev. 2024 Oct 2. doi: 10.1158/1055-9965.EPI-24-0581
    PubMed     Abstract available
    
    
    
82. ARANDA-GUTIERREZ A, Soto-Perez-de-Celis E
    The Disconnect between Clinical Guidelines and Reality: The Case of Trastuzumab.
    Cancer Epidemiol Biomarkers Prev. 2024;33:1259-1260.
    PubMed     Abstract available
    
    
    
83. ABE JV, Legaspi J, Guillermo C, Bogumil D, et al
    Breast, Colorectal, and Prostate Cancer Incidence among Filipino Americans by Generational Status in the Multiethnic Cohort Study.
    Cancer Epidemiol Biomarkers Prev. 2024;33:1311-1317.
    PubMed     Abstract available
    
    
    September 2024
84. WOJCIK KM, Wilson OWA, Shiels MS, Sheppard VL, et al
    Racial, Ethnic, and Socioeconomic Disparities in Meeting Physical Activity Guidelines among Female Breast Cancer Survivors in the United States.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
85. KALIA SS, Boddicker NJ, Yadav S, Huang H, et al
    Development of a breast cancer risk prediction model integrating monogenic, polygenic, and epidemiologic risk.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    August 2024
86. BRANTLEY KD, Ziegler RG, Craft NE, Hankinson SE, et al
    Circulating Estrogen Metabolites and Risk of Breast Cancer among Postmenopausal Women in the Nurses' Health Study.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
87. PARK GE, Kim SH, Han K
    A Large Cohort Study of Height and Mammographic Density in Relation to Breast Cancer Risk among Korean Women.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
88. SINGH RK, Getz KR, Kyeyune JK, Jeon MS, et al
    Aspirin Metabolites and Mammographic Breast Density in Premenopausal Women.
    Cancer Epidemiol Biomarkers Prev. 2024;33:1126-1128.
    PubMed     Abstract available
    
    
    July 2024
89. BHIMANI J, O'Connell K, Persaud S, Blinder V, et al
    Patient characteristics associated with intended non-guideline chemotherapy in women with stage I-IIIA breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
90. ANG BH, Teo SH, Ho WK
    Systematic review and meta-analysis of lifestyle and reproductive factors associated with risk of breast cancer in Asian women.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
91. NORRIS RP, Dew R, Greystoke A, Cresti N, et al
    Socio-demographic disparities in HER2+ breast cancer trastuzumab receipt: An English population-based study.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
92. ABUBAKAR M, Ahearn TU, Duggan MA, Lawrence S, et al
    Contribution of pre-diagnostic host factors to shaping the stromal microenvironment of breast cancer among sub-Saharan African women.
    Cancer Epidemiol Biomarkers Prev. 2024 Jul 3. doi: 10.1158/1055-9965.EPI-24-0390
    PubMed     Abstract available
    
    
    
93. OH H, Yaghjyan L, Heng YJ, Rosner B, et al
    Associations of Early-Life and Adult Anthropometric Measures with the Expression of Stem Cell Markers CD44, CD24, and ALDH1A1 in Women with Benign Breast Biopsies.
    Cancer Epidemiol Biomarkers Prev. 2024;33:933-943.
    PubMed     Abstract available
    
    
    June 2024
94. LOHANI KR, Nibbe AM, Vierkant RA, Pacheco-Spann LM, et al
    Understanding benign breast disease and subsequent breast cancer in Hispanic white females; a step closer to evidence-based management.
    Cancer Epidemiol Biomarkers Prev. 2024 Jun 5. doi: 10.1158/1055-9965.EPI-24-0204
    PubMed     Abstract available
    
    
    
95. YAGHJYAN L, Wang Z, Warner ET, Rosner B, et al
    Reproductive Factors Related to Childbearing and a Novel Automated Mammographic Measure, V.
    Cancer Epidemiol Biomarkers Prev. 2024;33:804-811.
    PubMed     Abstract available
    
    
    May 2024
96. YE Z, Nguyen TL, Dite GS, Maclnnis RJ, et al
    Mammographic texture versus conventional Cumulus measure of density in breast cancer risk prediction: a literature review.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
97. FREEMAN JQ, Huo D
    Addressing Social Determinants in the Era of Precision Medicine in Breast Cancer: Is It Sufficient to Reduce Disparities?
    Cancer Epidemiol Biomarkers Prev. 2024;33:635-637.
    PubMed     Abstract available
    
    
    
98. JATOI I
    Breast Cancer Screening: Can We Justify Deescalation?
    Cancer Epidemiol Biomarkers Prev. 2024;33:638-640.
    PubMed     Abstract available
    
    
    
99. PARK JE, Smith MA, Van Alsten SC, Walens A, et al
    Diffsig: Associating Risk Factors with Mutational Signatures.
    Cancer Epidemiol Biomarkers Prev. 2024;33:721-730.
    PubMed     Abstract available
    
    
    
100. VAN ALSTEN SC, Dunn MR, Hamilton AM, Ivory JM, et al
     Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by Geography and Socioeconomic Status.
     Cancer Epidemiol Biomarkers Prev. 2024;33:654-661.
     PubMed     Abstract available
     
     
     April 2024
101. PARADA H, Wu T, Hoh E, Rock CL, et al
     Red Blood Cell Polyunsaturated Fatty Acids and Mortality Following Breast Cancer.
     Cancer Epidemiol Biomarkers Prev. 2024.
     PubMed     Abstract available
     
     
     
102. COLLISTER JA, Liu X, Littlejohns TJ, Cuzick J, et al
     Assessing the value of incorporating a polygenic risk score with non-genetic factors for predicting breast cancer diagnosis in the UK Biobank.
     Cancer Epidemiol Biomarkers Prev. 2024.
     PubMed     Abstract available
     
     
     
103. MOSS JL, Geyer NR, Lengerich EJ
     Patterns of Cancer-Related Healthcare Access across Pennsylvania: Analysis of Novel Census Tract-Level Indicators of Persistent Poverty.
     Cancer Epidemiol Biomarkers Prev. 2024;33:616-623.
     PubMed     Abstract available
     
     
     
104. BARBER LE, McCullough LE, Johnson DA
     Eyes Wide Open: Sleep as a Potential Contributor to Racial and Ethnic Disparities in Cancer.
     Cancer Epidemiol Biomarkers Prev. 2024;33:471-479.
     PubMed     Abstract available
     
     
     
105. HAN E, Van Horn L, Snetselaar L, Shepherd JA, et al
     The Associations between Intakes of One-Carbon Metabolism-Related Vitamins and Breast Density among Young Women.
     Cancer Epidemiol Biomarkers Prev. 2024;33:567-575.
     PubMed     Abstract available
     
     
     March 2024
106. SIEGEL SD, Zhang Y, Lynch SM, Rowland J, et al
     A Novel Approach for Conducting a Catchment Area Analysis of Breast Cancer by Age and Stage for a Community Cancer Center.
     Cancer Epidemiol Biomarkers Prev. 2024 Mar 7. doi: 10.1158/1055-9965.EPI-23-1125
     PubMed     Abstract available
     
     
     
107. LEE M, Kotake R, Yamauchi H
     Physical Activity and Mammographic Density in Japanese Women.
     Cancer Epidemiol Biomarkers Prev. 2024;33:365-370.
     PubMed     Abstract available
     
     
     February 2024
108. FARBER R, Houssami N, McGeechan K, Barratt A, et al
     Breast cancer stage and size detected with film versus digital mammography in New South Wales, Australia: a population-based study using routinely collected data.
     Cancer Epidemiol Biomarkers Prev. 2024.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum